SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs >

Spectrum Pharmaceutecals, Inc. (SPPI)

SPPI RSS Feed
Add SPPI Price Alert      Hide Sticky   Hide Intro
Moderator: Ville7, antihama
Search This Board: 
Last Post: 8/22/2017 6:47:32 PM - Followers: 75 - Board type: Free - Posts Today: 1

http://www.spectrumpharm.com/

http://finance.yahoo.com/q/ks?s=SPPI+Key+Statistics

Company Presentation

http://www.sppirx.com/704-corporate-presentation.html

Spectrum Development Pipeline/Portfolio

Fusilev® (Levoleucovorin) for injection FDA Approved on April 29, 2011 for Use in Patients with Advanced Metastatic Colorectal Cancer and FDA Approved on March 7, 2008 for High-Dose Methotrexate Rescue Therapy in Osteosarcoma.
Zevalin® (ibritumomab tiuxetan), an FDA-Approved, Proprietary, Biological Drug for Indolent Non-Hodgkin's Lymphoma.
Belinostat a novel HDAC inhibitor in late stage clinical development for Peripheral T-cell Lymphoma, and other Solid Tumors (including Carcinoma of Unknown Primary, etc.)
Apaziquone, one of our lead development candidates, is a synthetic bio-reductive prodrug that is being investigated in the treatment of non-invasive bladder cancer, and began two Phase 3 studies in 2007.Spectrum also has three drugs in the Phase 2 stage of development: Ozarelix, for the treatment of prostate cancer and Ortataxel, for the treatment of taxane-refractory tumors.
The Company has three drugs in the Phase 1 stage of development: SPI-1620, an adjunct to chemotherapy, Elsamitrucin, which will target advanced solid tumors and Lucanthone, a chemotherapy sensitizer in the treatment of recurrent, malignant brain tumors.
Other drugs in development include SPI-014, used in the treatment of hyperphosphotemia in end stage renal disease (ESRD), and SPI-205 for chemotherapy induced neuropathy.

Recent News (Zevalin):

http://investor.spectrumpharm.com/releasedetail.cfm?ReleaseID=632354
http://investor.spectrumpharm.com/releasedetail.cfm?ReleaseID=632346

.  

 

SPPI
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SPPI News: Spectrum Pharmaceuticals to Present Corporate Update at the 2017 Southern California Investor Conference in Newport Beach on ... 08/17/2017 07:00:00 AM
SPPI News: Spectrum Pharmaceuticals Announces Initiation of the Registrational Phase 3 Trial of Qapzola™ (apaziquone) in Patients with... 08/14/2017 07:00:00 AM
SPPI News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 08/04/2017 05:11:32 PM
SPPI News: Current Report Filing (8-k) 08/04/2017 05:08:30 PM
SPPI News: Quarterly Report (10-q) 08/04/2017 05:00:17 PM
PostSubject
#1744   Regarding Spectrum currently holds a Zacks Rank #2 antihama 08/22/17 06:47:31 PM
#1743   Breast cancer P2 Poziotinib info from 2015 SABCS. antihama 08/18/17 03:56:05 PM
#1742   Spectrum currently holds a Zacks Rank #2 (Buy)! antihama 08/17/17 07:55:07 AM
#1741   future stock price should be at least $14.20 antihama 08/16/17 07:57:21 AM
#1740   H.C. Wainwright ups SPPI price target to $14 antihama 08/16/17 07:47:21 AM
#1739   Selling Rolontis Do’s and Don’ts once approved. This antihama 08/15/17 12:34:12 PM
#1738   The PR for start of Qapzola Patient enrollment antihama 08/15/17 11:45:41 AM
#1737   New SA article, second one in a month. antihama 08/08/17 06:20:45 PM
#1736   Ziggy, a realistic near future stock price is… antihama 08/07/17 03:39:38 PM
#1735   what do you think a realistic near future Zippyry 08/06/17 10:58:21 AM
#1734   Correction - Getting 5M later this year for antihama 08/06/17 08:09:49 AM
#1733   2nd Q PR and CC impressions. As previously antihama 08/05/17 03:59:59 PM
#1732   Poziotinib - most exciting cancer drug results seen Just Jack 08/04/17 03:19:45 PM
#1731   I've been away from my computer since before antihama 08/04/17 12:47:11 PM
#1730   "So i expect SPPI to go higher from Ville7 08/04/17 10:02:01 AM
#1729   expected newsflow ( (c) Ville ): Ville7 08/04/17 06:23:23 AM
#1728   Just when the call started, I had to antihama 08/03/17 05:56:07 PM
#1727   Did they mention the Hanmi "proffered paper" in Ville7 08/03/17 05:45:23 PM
#1726   Q2 $34.3M Revenue beats by $3.8M;EPS beats by $0.16. antihama 08/03/17 04:30:26 PM
#1725   Poziotinib EGFR Exon 20 Insertion mutation paper to antihama 08/02/17 05:54:01 PM
#1724   Today's PR includes the word "Pivotal" in title. antihama 08/01/17 07:45:18 AM
#1723   Next expecting to see 'ongoing, not recruiting' on antihama 08/01/17 07:31:52 AM
#1722   combo trial of poziotinib w T-DM1 mentioned during antihama 07/31/17 03:16:31 PM
#1721   Ditto on the 2nd (EU) Rolontis P3. It antihama 07/31/17 03:07:35 PM
#1720   Since my previous post, I kept on wondering antihama 07/31/17 02:50:13 PM
#1719   If they make decisions to include a wider antihama 07/27/17 04:16:12 PM
#1718   " The US mBC trial is for HER2 Ville7 07/27/17 02:22:10 PM
#1717   Exactly! Here is another one for you. antihama 07/27/17 10:09:57 AM
#1716   As antihama is looking forward to the breast Ville7 07/27/17 09:47:13 AM
#1715   SOC OS for HER2 mBC at 1, 2, antihama 07/27/17 09:24:39 AM
#1714   Folks, Ville back as a Bull is truly antihama 07/26/17 04:40:50 PM
#1713   Proffered paper is really data of high significance. antihama 07/26/17 04:29:15 PM
#1712   So after many dark years i am back Ville7 07/26/17 12:17:13 PM
#1711   "I therefor think that they reached the 30% Ville7 07/26/17 12:11:41 PM
#1710   "Hope you are right regarding the poziotinib Korean Ville7 07/26/17 12:07:28 PM
#1709   New Phase 3 Study (NCT03224182) of Qapzola (Apaziquone) antihama 07/26/17 08:50:43 AM
#1708   Exon 20 Mutation trial changes doesn't change anything! antihama 07/25/17 03:11:01 PM
#1707   Hi Ville, of course, I know you from antihama 07/25/17 02:11:34 PM
#1706   11,000 pts w exon 20 mutations who benefit antihama 07/25/17 01:57:55 PM
#1705   Poziotinib Hey antihama, Ville7 07/25/17 01:44:00 PM
#1704   How many patients have EGFR exon 20 insertions antihama 07/25/17 01:04:11 PM
#1703   Significant change to the EGFR Exon 20 Mutation antihama 07/24/17 06:41:23 PM
#1702   It's a Late Breaking Abstract! Per ESMO Late-breaking antihama 07/24/17 06:07:57 PM
#1701   Poziotinib - HANMI Phase II results Just Jack 07/24/17 12:34:45 PM
#1700   Spectrum Pharma vs Nabriva Therapeutics Head-To-Head Comparison. I antihama 07/22/17 12:27:54 PM
#1699   Yeah, it's looking good! antihama 07/20/17 09:37:22 PM
#1698   Just confirming I'm not blowing smoke up my antihama 07/20/17 09:29:07 PM
#1697   We hit the 52 week high this morning, Just Jack 07/20/17 10:21:16 AM
#1696   Another large volume day (1.83M) yesterday w SP antihama 07/14/17 08:05:10 AM
#1695   Large block buy - wish it was me, Just Jack 07/13/17 01:58:30 PM
PostSubject